Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC ↓	Name	B/G	Ingredients	Dosage	Form	Price
S02AA30	TYOTOCIN	B	Hexylresorcinol - 0.1%, Antipyrine - 5%, Benzocaine - 1.25%, Tyrothricin - 0.05%		Drops solution	409,552 L.L
S01XA20	TEARS NATURALE	B	Duasorb - 0.4%	0.4%	Drops solution	189,482 L.L
S01FA06	TROPICIL TOP	G	Tropicamide - 10mg/ml	10mg/ml	Drops solution	200,233 L.L
S01EE04	TRAVATAN	B	Travoprost - 40mcg/ml	0.004%	Drops solution	806,306 L.L
S01EE04	TRAVOPROST BIOGARAN		Travoprost - 40mcg/ml	40mcg/ml	Drops solution	564,414 L.L
S01ED51	TWINZOL	G	Dorzolamide HCl - 2%, Timolol - 0.5%		Drops solution	632,950 L.L
S01ED51	TRAVOPROST/TIMOLOL BIOGARAN	G	Travoprost - 40mcg/ml, Timolol - 5mg/ml		Drops solution	849,308 L.L
S01AE06	TYMER	G	Gatifloxacin (sesquihydrate) - 3mg/ml	3mg/ml	Drops solution	427,342 L.L
S01AA12	TOBRASTILL	G	Tobramycin - 0.3%	0.3%	Drops solution	258,018 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Drops	322,522 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Ointment	280,863 L.L
S01AA09	TETRACYCLINE EYE OINTMENT	G	Tetracycline HCl - 1%	1%	Ointment	71,672 L.L
R06AD08	TOPLEXIL	B	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup	615,480 L.L
R05X	TRIMEDIL FORTE	G	O-(?-hydroxyethyl)-rutosides - 30mg, Ascorbic acid - 80mg, Dimethindene - 0.5mg, Phenylephrine HCl - 2.5mg, Paracetamol - 200mg		Capsule	386,515 L.L
R05FA02	TUSCALMAN A	B	Noscapine HCl - 5mg, Guaifenesin - 25mg		Suppository	569,093 L.L
R05FA02	TUSCALMAN B	B	Noscapine HCl - 10mg, Guaifenesin - 50mg		Suppository	560,924 L.L
R05DB13	TUSSIN	G	Butamirate citrate - 7.5mg/5ml	7.5mg/5ml	Syrup, sugar free	296,925 L.L
R05DB13	TUSSIN	G	Butamirate citrate - 7.5mg/5ml	7.5mg/5ml	Syrup, sugar free	154,862 L.L
R05CB01	TREBON N	G	Acetylcysteine - 600mg	600mg	Granules for suspension	596,666 L.L
R05CA12	TOUCALM	G	Dried Ivy leaf extract - 0.7g/100ml	0.7g/100ml	Syrup	300,765 L.L
R03DB05	THEODEX	G	Ipeca fluide extract - 20mg, Aminophylline - 150mg, Caffeine - 100mg, Ephedrine - 15mg		Tablet	156,142 L.L
R03DA04	THEOSOL ELIXIR	G	Théophylline - 25mg/5ml	25mg/5ml	Elixir	312,283 L.L
R03DA04	THEODEX	G	Theophylline - 80mg/15ml	80mg/15ml	Elixir	156,142 L.L
R03BB04	TIOVA-T	G	Tiotropium bromide monohydrate - 18mcg	18mcg	Rotacaps	384,339 L.L
R02A	TRACHISAN	G	Lidocaine HCl - 1mg, Tyrothricin - 0.5mg, Chlorhexidine gluconate - 1mg		Lozenge	228,453 L.L
R01AD09	TABUNEX	G	Mometasone furoate - 0.05%	0.05%	Spray	419,279 L.L
R01AD08	TICANASE	G	Fluticasone propionate - 50mcg/actuation	12g/Bottle	Spray, suspension	405,840 L.L
R01AB06	TRIOFAN	B	Xylometazoline HCl - 0.5mg/ml, Carbocysteine - 5mg/ml		Spray, solution	608,761 L.L
R01AB06	TRIOFAN	B	Xylometazoline HCl - 1mg/ml, Carbocysteine - 10mg/ml		Spray, solution	646,388 L.L
P02DA01	TAENIASAN	G	Niclosamide - 500mg	500mg	Tablet	94,709 L.L